NEW ORLEANS, LA—Recombinant factor VIIa slowed hematoma growth in patients with a spontaneous intracerebral hemorrhage (ICH) when administered within 2 hours of onset, but treatment significantly ...
October 10, 2007 (Seattle) — A report from a military emergency unit in Iraq may indicate that a change in the timing of administration of recombinant factor VIIa (rFVIIa) could significantly improve ...
NEW ORLEANS — A new trial of recombinant factor VIIa in patients with intracerebral hemorrhage (ICH) showed neutral overall results but raised the possibility that the therapy could help stop bleeding ...
Factor VII deficiency is a rare, autosomal recessive bleeding disorder marked by reduced levels or dysfunction of coagulation factor VII, a crucial initiator of the extrinsic coagulation cascade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results